> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA to Study Breast Implant Risk Perception
- URL: https://www.fdaweb.com/fda-to-study-breast-implant-risk-perception/
- Published: 2022-06-14T12:00:00.000Z
- Updated: 2026-09-14T17:48:33.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5152063

FDA says it has contracted with Research Triangle Institute International to study how patients weigh the benefits and risks associated with smooth and textured breast implants. An agency [announcement](https://www.fda.gov/news-events/press-announcements/fda-roundup-june-14-2022?ref=fdaweb.com) says CDRH believes the survey results will help assess whether patients’ perception of the risk of breast implant-associated anaplastic large cell lymphoma associated with textured breast implants is influenced by information about the potential benefits of the textured implants.

The insights gained through this patient-centered approach will help incorporate patient preferences in CDRH's regulatory decision-making, the notice says. CDRH says it plans to publish the results of this study later this year.